302440.KO SK Bioscience Co Ltd

Healthcare Biotechnology Korea Stock Exchange
36,950 KRW
Close of Nov 5, 2026
31,500 56,500
Market cap
KRW 2.90T
P/E
-
P/B
1.55x
ROE
-5.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 302440.KO undervalued?

Graham number

The Graham number of SK Bioscience Co Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

SK Bioscience Co Ltd fundamental analysis

No fundamental analysis for SK Bioscience Co Ltd yet.

SK Bioscience Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About SK Bioscience Co Ltd

SK bioscience Co.,Ltd. engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally. Its product portfolio includes Skycellflu, a cell cultured influenza surface antigen vaccine; Skycellflu 4-ga pre-filled syringe; pneumococcal vaccine for adult and infant; Skyzoster, a shingles virus vaccine; and Sky Baricella for the prevention of chickenpox infection in children. The company also engages in the devel…

Full company profile